Title
T1-Weighted Dynamic Contrast-Enhanced MRI Is a Noninvasive Marker of Epidermal Growth Factor Receptor vIII Status in Cancer Stem Cell-Derived Experimental Glioblastomas
UMMS Affiliation
Department of Radiology
Publication Date
6-1-2016
Document Type
Response or Comment
Disciplines
Neoplasms | Neurology | Radiology
Abstract
We read with great interest the article by Arevalo-Perez et al, describing the potential value of T1-weighted dynamic contrast-enhanced MR imaging (DCE-MR imaging) as a biomarker for epidermal growth factor receptor variant III (EGFRvIII) mutation in patients with glioblastoma (GBM).
DOI of Published Version
10.3174/ajnr.A4774
Source
AJNR Am J Neuroradiol. 2016 Jun;37(6):E49-51. Mar 17. Link to article on publisher's site
Journal/Book/Conference Title
AJNR. American journal of neuroradiology
Related Resources
PubMed ID
26988813
Repository Citation
Politi, Letterio S.; Brugnara, G.; Castellano, A.; Cadioli, M.; Altabella, L.; Peviani, M.; Mazzoleni, S.; Falini, A.; and Galli, R., "T1-Weighted Dynamic Contrast-Enhanced MRI Is a Noninvasive Marker of Epidermal Growth Factor Receptor vIII Status in Cancer Stem Cell-Derived Experimental Glioblastomas" (2016). Radiology Publications and Presentations. 229.
https://escholarship.umassmed.edu/radiology_pubs/229